Skip to content

Medical emergency? What to do

Fewer kids on SSRI antidepressants

3-RXPublished July 4, 20072 min read

Key points

  • Within 2 years after the October 2003 FDA public health advisory about the risk of suicide in children taking a type of antidepressant called selective serotonin reuptake inhibitors (SSRIs), significant reductions in rates of diagnosis and antidepressant treatment of childhood depression occurred, researchers report.
  • However, "we were most surprised at the diagnosing rate decline, reversing a national trend as evidence of a decade of work to educate and promote depression treatment in primary care," she added.
  • She and colleagues used a large national claims database of more than 85 managed care plans to analyze data on 65,349 children aged 5 to 18 years who were diagnosed with depression between October 1998 and September 2005.
  • "The most important observations," noted Libby, are that, after the October 2003 public health advisory on SSRIs in children, "national rates of new depression diagnoses are significantly lower than what the historical trend would have predicted."

Within 2 years after the October 2003 FDA public health advisory about the risk of suicide in children taking a type of antidepressant called selective serotonin reuptake inhibitors (SSRIs), significant reductions in rates of diagnosis and antidepressant treatment of childhood depression occurred, researchers report.

"Antidepressant use was expected to decline, consistent with effects on other drugs after warnings are issued," Dr. Anne M. Libby of University of Colorado Health Science Center at Denver told Reuters Health.

However, "we were most surprised at the diagnosing rate decline, reversing a national trend as evidence of a decade of work to educate and promote depression treatment in primary care," she added.

"Our concern is the lack of treatment for a disorder that is quite serious in childhood, as depression is a large and significant risk factor for suicide," Libby added.

She and colleagues used a large national claims database of more than 85 managed care plans to analyze data on 65,349 children aged 5 to 18 years who were diagnosed with depression between October 1998 and September 2005.

They used time-series models to compare depression diagnoses and antidepressant prescribing trends during the 2 years after the FDA advisory and the expected trends based on data from the 5-year period preceding the advisory.

"The most important observations," noted Libby, are that, after the October 2003 public health advisory on SSRIs in children, "national rates of new depression diagnoses are significantly lower than what the historical trend would have predicted."

Among those who were diagnosed with depression, the proportion of cases that received antidepressants in the first 30 days were far lower than would have been expected based on the historical trend, authors report in the American Journal of Psychiatry.

Of concern, however, for those newly diagnosed pediatric patients, "there was not strong evidence of other types of treatment to make up that gap, whether psychosocial 'talk' therapy or other psychotropic medications," Libby told Reuters Health.

Dr. Cynthia R. Pfeffer, from New York Presbyterian Hospital, New York, who was not involved in the study, warns that the FDA advisories "may have had the unintended effect of discouraging the prescription of antidepressants for pediatric patients and pediatric utilization of antidepressants without compensatory increases in other specific treatments."

SOURCE: American Journal of Psychiatry, June 2007.

The content on this site is for information only and is not a substitute for professional medical advice, diagnosis or treatment. Drug information pages are an archive and may be out of date: always follow your prescriber, your pharmacist and the current product label. In an emergency, call 911.

Keep reading

Drug News

Drug shows early promise in treating seizures

A study out today in the journal Nature Medicine suggests a potential new treatment for the seizures that often plague children with genetic metabolic disorders and individuals undergoing liver failure. The discovery…

5 min read

When to get help

Reading is for later. These need care now.

Call 911 or go to an emergency department if you or someone with you has any of these:

  • Chest pain or pressureEspecially with breathlessness, sweating or pain in the arm, jaw or back. It can be a heart attack.
  • Face drooping, arm weakness, slurred speechSigns of a stroke. Note the time they started: treatment works best within hours.
  • Severe trouble breathingIncluding a severe allergic reaction with swelling of the lips, tongue or throat.
  • Thoughts of suicideCall or text 988 (Suicide & Crisis Lifeline, US) any time, day or night.

Outside the US, call your local emergency number.

See a doctor within days

  1. 01A new lump, or a sore that does not healMost lumps are harmless, but anything that grows or lasts more than a few weeks should be checked.
  2. 02Unexplained weight loss or lasting fatigueLosing weight without trying, or tiredness that does not lift, can have many causes worth finding.
  3. 03A new medicine and new symptomsSide effects and interactions are common. Ask your pharmacist or prescriber before you stop anything.

General guidance only. If you are unsure how urgent a symptom is, call your doctor or a nurse advice line.